Respiratory Delivery of Biologics, Nucleic Acids, and Vaccines
Respiratory Delivery of Biologics, Nucleic Acids, and Vaccines [electronic resource] /
edited by Jenny Lam, Philip Chi Lip Kwok.
- 1st ed. 2023.
- X, 216 p. 21 illus., 20 illus. in color. online resource.
- AAPS Introductions in the Pharmaceutical Sciences, 8 2522-8358 ; .
- AAPS Introductions in the Pharmaceutical Sciences, 8 .
Acceso multiusuario
Chapter 1: Design strategies of dry powders for pulmonary delivery of pharmaceutical peptides -- Chapter 2. Pulmonary delivery of antibody for the treatment of respiratory diseases -- Chapter 3: Dry powder formulation of monoclonal antibodies for pulmonary delivery -- Chapter 4: Antimicrobial peptides and proteins for inhalation -- Chapter 5: Pulmonary delivery of nucleic acids -- Chapter 6: Intranasal and inhaled vaccines -- Chapter 7: Respiratory delivery of probiotics to improve lung health -- Chapter 8: Respiratory delivery of bacteriophages for the treatment of lung infections -- Chapter 9: Pharmacokinetics of inhaled medications - what do we know about biological macromolecules?.
Therapeutic macromolecules and biologics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these therapeutic modalities, which have poor oral bioavailability, could constitute an attractive, non-invasive alternative to parenteral delivery. They can be considered for either topical use for treating diseases affecting the airways or for systemic use for treating a variety of other diseases. Therefore, this book is a readable, thoughtful, and useful guide on the latest research developments and the best options that people involved with pulmonary and intranasal route of administration and biologically active agents can bring to their practices. Furthermore, it explores the underlying scientific rationale for the strategies applied to overcome drug delivery challenges and provides insights to inspire further research in this growing area.
9783031475672
Pharmaceutical chemistry.
Drug delivery systems.
Biologicals.
Biopharmaceutics.
Vaccines--Biotechnology.
Biomaterials.
Drugs--Design.
Pharmacology.
Pharmaceutics.
Drug Delivery.
Biologics.
Biomaterials-Vaccines.
Structure-Based Drug Design.
Pharmacology.
RS400-431
615.19
Acceso multiusuario
Chapter 1: Design strategies of dry powders for pulmonary delivery of pharmaceutical peptides -- Chapter 2. Pulmonary delivery of antibody for the treatment of respiratory diseases -- Chapter 3: Dry powder formulation of monoclonal antibodies for pulmonary delivery -- Chapter 4: Antimicrobial peptides and proteins for inhalation -- Chapter 5: Pulmonary delivery of nucleic acids -- Chapter 6: Intranasal and inhaled vaccines -- Chapter 7: Respiratory delivery of probiotics to improve lung health -- Chapter 8: Respiratory delivery of bacteriophages for the treatment of lung infections -- Chapter 9: Pharmacokinetics of inhaled medications - what do we know about biological macromolecules?.
Therapeutic macromolecules and biologics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these therapeutic modalities, which have poor oral bioavailability, could constitute an attractive, non-invasive alternative to parenteral delivery. They can be considered for either topical use for treating diseases affecting the airways or for systemic use for treating a variety of other diseases. Therefore, this book is a readable, thoughtful, and useful guide on the latest research developments and the best options that people involved with pulmonary and intranasal route of administration and biologically active agents can bring to their practices. Furthermore, it explores the underlying scientific rationale for the strategies applied to overcome drug delivery challenges and provides insights to inspire further research in this growing area.
9783031475672
Pharmaceutical chemistry.
Drug delivery systems.
Biologicals.
Biopharmaceutics.
Vaccines--Biotechnology.
Biomaterials.
Drugs--Design.
Pharmacology.
Pharmaceutics.
Drug Delivery.
Biologics.
Biomaterials-Vaccines.
Structure-Based Drug Design.
Pharmacology.
RS400-431
615.19
